PFS
GTBP icon

Prospera Financial Services’s GT Biopharma GTBP Stock Holding History

Prospera Financial Services’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12K Buy
12,500
+504
+4% +$204 ﹤0.01% 1466
2026
Q1 		$4.89K Hold
11,996
– – ﹤0.01% 1416
2025
Q4 		$9.42K Buy
+11,996
New +$8.52K ﹤0.01% 1357

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WFA
West Financial Advisors Des Moines, Iowa $659M AUM 17.93% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Prospera Financial Services's GTBP Position: Q2 2026 in Review

Prospera Financial Services increased its GT Biopharma (GTBP) stake by 4.2% in Q2 2026, buying an estimated $204 and bringing the position to 12,500 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

Prospera Financial Services first reported a position in GTBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.42K in Q4 2025. 12 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Prospera Financial Services held 12,500 shares of GT Biopharma worth $6.12K as of Q2 2026.
  • Prospera Financial Services bought 504 GT Biopharma shares in Q2 2026, an estimated $204.
  • GT Biopharma made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1466 holding.
  • Prospera Financial Services first reported a position in GT Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Prospera Financial Services's GT Biopharma position peaked at $9.42K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.